000011144 001__ 11144
000011144 005__ 20250218124743.0
000011144 02470 $$ahttps://doi.org/10.1001/jamanetworkopen.2019.2546$$2doi
000011144 037__ $$aTEXTUAL
000011144 037__ $$bArticle
000011144 041__ $$aeng
000011144 245__ $$aKeeping checkpoint inhibitors in check
000011144 269__ $$a2019-05-03
000011144 336__ $$aArticle
000011144 520__ $$aNo abstract
000011144 540__ $$a<p>© 2019 Catenacci DVT et al.</p><p>This is an open access article distributed under the terms of the <a href=”https://jamanetwork.com/pages/cc-by-license-permissions”>CC-BY</a> License.</p>
000011144 542__ $$fCC BY
000011144 690__ $$aBiological Sciences Division
000011144 691__ $$aMedicine
000011144 7001_ $$aCatenacci, Daniel V.T.$$uUniversity of Chicago
000011144 7001_ $$aHochster, Howard$$uRutgers Cancer Institute of New Jersey
000011144 7001_ $$aKlempner, Samuel J.$$uThe Angeles Clinic and Research Institute
000011144 773__ $$tJAMA Network Open
000011144 8564_ $$yArticle$$98bf45b45-2406-4c73-8712-a707da9a4144$$s316691$$uhttps://knowledge.uchicago.edu/record/11144/files/catenacci_2019_ic_190029.pdf$$ePublic
000011144 908__ $$aI agree
000011144 909CO $$ooai:uchicago.tind.io:11144$$pGLOBAL_SET
000011144 983__ $$aArticle